Skip to main content
Journal ArticleOPEN ACCESS

Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery

  • Alvarez‐Escola C
  • Cárdenas‐Salas J
  • Pelegrina B
  • et al.
Clinical Case Reports (2015) 3(11) 945-948
DOI: 10.1002/ccr3.388
N/ACitations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH / IGF ‐1 levels, but a direct effect cannot be ruled out.

Cite

CITATION STYLE

APA

Alvarez‐Escola, C., Cárdenas‐Salas, J. J., Pelegrina, B., Sanz‐Valtierra, A., & Lecumberri, B. (2015). Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery. Clinical Case Reports, 3(11), 945–948. https://doi.org/10.1002/ccr3.388

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free